Cantor Fitzgerald issued a coverage report on AbCellera, a company whose shares trade on Nasdaq.
4 reports, 3 independent
Updated Nov 4
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald issued a coverage report on AbCellera, a company whose shares trade on Nasdaq.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Jefferies started coverage and Truist raised its price objective for AbCellera.1 source
Cantor Fitzgerald issued coverage report on AbCellera shares trading on Nasdaq.1 source
Keep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
-
AbCellera
company in Vancouver, Canada
Related events
- Cantor Fitzgerald, Citigroup, and MarketBeat issued rating updates and price targets for Rigel Pharmaceuticals, Inc.
- Cantor Fitzgerald upgraded BMNR shares to strong-buy on July 1, 2026.
- Benzinga reported analyst research notes and Cantor Fitzgerald decreased its price objective for EMCOR Group, Inc.
- Cantor Fitzgerald restated an overweight rating for MoonLake Immunotherapeutics, which trades on Nasdaq, with data provided by MarketBeat.
- Mastercard extended digital payment access in Morocco and partnered with OpenAI, while Cantor Fitzgerald and Raymond James Financial updated ratings.